tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AGIO Stock Latest News

Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
Company AnnouncementsAgios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
12h ago
8K
AGIO
Agios Pharmaceuticals outlines 2026 strategic priorities
PremiumThe Fly
Agios Pharmaceuticals outlines 2026 strategic priorities
12h ago
AGIO
Agios Pharmaceuticals price target raised to $35 from $34 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target raised to $35 from $34 at BofA
6d ago
AGIO
Agios Pharmaceuticals price target raised to $25 from $20 at JPMorgan
PremiumThe Fly
Agios Pharmaceuticals price target raised to $25 from $20 at JPMorgan
6d ago
AGIO
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
PremiumRatings
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
17d ago
AGIO
Agios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
PremiumRatingsAgios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
18d ago
AGIO
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
Premium
Ratings
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
19d ago
AGIO
Agios Pharmaceuticals price target raised to $62 from $48 at H.C. Wainwright
Premium
The Fly
Agios Pharmaceuticals price target raised to $62 from $48 at H.C. Wainwright
19d ago
AGIO
Agios Pharmaceuticals price target raised to $38 from $32 at Truist
PremiumThe Fly
Agios Pharmaceuticals price target raised to $38 from $32 at Truist
19d ago
AGIO
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
PremiumMarket News
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
19d ago
AGIO
Agios Pharmaceuticals’ Aqvesme to be introduced at $425K per patient per year
PremiumThe Fly
Agios Pharmaceuticals’ Aqvesme to be introduced at $425K per patient per year
19d ago
AGIO
Agios Pharmaceuticals price target raised to $34 from $32 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target raised to $34 from $32 at BofA
20d ago
AGIO
FDA approves Agios Pharmaceuticals’ Aqvesme in anemia patients
PremiumThe FlyFDA approves Agios Pharmaceuticals’ Aqvesme in anemia patients
20d ago
AGIO
Agios Pharmaceuticals trading halted, news pending
Premium
The Fly
Agios Pharmaceuticals trading halted, news pending
20d ago
AGIO
Agios Pharma: Hold Rating Amid Regulatory Uncertainty and Gradual Market Launch
Premium
Ratings
Agios Pharma: Hold Rating Amid Regulatory Uncertainty and Gradual Market Launch
1M ago
AGIO
Anticipated FDA Approval of Agios Pharma’s Pyrukynd Expected to Boost Stock Value
PremiumRatings
Anticipated FDA Approval of Agios Pharma’s Pyrukynd Expected to Boost Stock Value
1M ago
AGIO
Morning Movers: Confluent surges following deal to be bought by IBM
PremiumThe Fly
Morning Movers: Confluent surges following deal to be bought by IBM
1M ago
ITT
AGIO
Agios Pharmaceuticals says FDA has not yet issued decision for mitapivat sNDA
PremiumThe Fly
Agios Pharmaceuticals says FDA has not yet issued decision for mitapivat sNDA
1M ago
AGIO
Agios Pharmaceuticals initiated with a Buy at Citi (yesterday)
PremiumThe Fly
Agios Pharmaceuticals initiated with a Buy at Citi (yesterday)
2M ago
AGIO
Agios Pharmaceuticals initiated with a Buy at Truist
PremiumThe FlyAgios Pharmaceuticals initiated with a Buy at Truist
2M ago
AGIO
Agios Pharmaceuticals price target lowered to $20 from $37 at JPMorgan
Premium
The Fly
Agios Pharmaceuticals price target lowered to $20 from $37 at JPMorgan
2M ago
AGIO
Agios Pharmaceuticals price target lowered to $25 from $40 at Goldman Sachs
Premium
The Fly
Agios Pharmaceuticals price target lowered to $25 from $40 at Goldman Sachs
2M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >